Background: Recently, immune check point inhibitors (ICIs)-therapy play an important role in multidisciplinary treatment of cancer. ICIs are newly antibody agent which reactivate T-cells in cancer patients. The other, it is problem that ICIs quite expensive and have severe side-effects. In the present report, we investigated the effects of team treatment and supportive care on ICI-treat outpatients. Methods: The study subjects were patients of melanoma which may be treated by ICI in 2years. After Dr.'s consultation, pharmacist explain agent efficacy, application schedule, side-effects and them relief procedures, medial deduction and treatment pay. Then, Nurses execute guidance of self-care management. In therapy, medical staffs monitor side-effects by used checklist for common use. If it was indicated severe adverse event on patient, a dermatologist consult doctors of medical specialty. Results: Nivolumab and ipilimumab-treatment patients were six and one, respectively. In each of treatment day, we checked digestive disturbance, dermopathy, myopathy and neuropathy. We monitored laboratory evidence in relation to liver and renal dysfunction, hypothyroidism and hyperglycemia. In purpose of discrimination of interstitial pneumonia, we confirmed image inspection and auscultated chest. As a result, we checked each one patient of pneumonia, grade3/4 anemia, grade1/2 hypotension, grade3 persistent neutropenia and myelodysplastic syndrome, and patients could continue therapy by managed their symptom in nivolumab treatment group. Conclusion: Our results indicate that we can execute efficient and high-quality ICIstreatment in busy ambulatory practice and chemotherapy on outpatients. Therefore, it is possible that medical staffs dispose quickly and appropriately on side-effects by sharing of patient intelligences and establishing of supportive care procedures in treatment. We should assure treatment safety and medical satisfaction of patients on ICIs-therapy. Background: Health-related quality of life presents an alternative way for evaluating consequences of experiencing delays among cancer patients and it has become a wellestablished end point to determine the impacts of the disease on the life of patients. Delays in patient presentations to the medical professionals and delays in treatments are factors that lead to a progression of cancer and increase in mortality rates. The aim of this study is to know the association between health-related quality of life with patient presentation and treatment delays in Indonesia. Methods: This is a cross sectional study that took place in Siloam General Hospital, a suburban area of Tangerang from July 2016 to January 2017. Only solid-type cancers were included in our study. Health related quality of life was measured using EORTC QLQ-C30. Patients were classified as patient delays if the time from first symptoms to medical presentation were more than 3 months and classified as treatment delays if the time from diagnosis to medical treatment was more than 1 month. The statistical analysis was done by Independent T or Mann-Whitney test. Results: Out of a total of 56 patients, 50(89.3%) were female. The mean age of the patient was 48.6(þ/-10.9). The most common type of cancer was breast cancer (76.7%), followed by adenocarcinoma of the colon (8.9%). Patient delay and treatment delay were present in 24 (42.9%) and 21 (37.5%) patients respectively. Patient delay had significant association with global health status (p ¼ 0.042), emotional functioning (p ¼ 0.017), symptoms such as fatigue (p ¼ 0.004) and appetite loss (p ¼ 0.026). Treatment delay had significant association with global health status (p ¼ 0.010), physical functioning (p ¼ 0.013), emotional functioning (p ¼ 0.027). The other subscales of quality of life had no significant association with patient delay and treatment delay. Conclusion: Patient and treatment delay were associated with poorer health-related quality of life.
Background: Recently, immune check point inhibitors (ICIs)-therapy play an important role in multidisciplinary treatment of cancer. ICIs are newly antibody agent which reactivate T-cells in cancer patients. The other, it is problem that ICIs quite expensive and have severe side-effects. In the present report, we investigated the effects of team treatment and supportive care on ICI-treat outpatients. Methods: The study subjects were patients of melanoma which may be treated by ICI in 2years. After Dr.'s consultation, pharmacist explain agent efficacy, application schedule, side-effects and them relief procedures, medial deduction and treatment pay. Then, Nurses execute guidance of self-care management. In therapy, medical staffs monitor side-effects by used checklist for common use. If it was indicated severe adverse event on patient, a dermatologist consult doctors of medical specialty. Results: Nivolumab and ipilimumab-treatment patients were six and one, respectively. In each of treatment day, we checked digestive disturbance, dermopathy, myopathy and neuropathy. We monitored laboratory evidence in relation to liver and renal dysfunction, hypothyroidism and hyperglycemia. In purpose of discrimination of interstitial pneumonia, we confirmed image inspection and auscultated chest. As a result, we checked each one patient of pneumonia, grade3/4 anemia, grade1/2 hypotension, grade3 persistent neutropenia and myelodysplastic syndrome, and patients could continue therapy by managed their symptom in nivolumab treatment group. Conclusion: Our results indicate that we can execute efficient and high-quality ICIstreatment in busy ambulatory practice and chemotherapy on outpatients. Therefore, it is possible that medical staffs dispose quickly and appropriately on side-effects by sharing of patient intelligences and establishing of supportive care procedures in treatment. We should assure treatment safety and medical satisfaction of patients on ICIs-therapy. Background: Health-related quality of life presents an alternative way for evaluating consequences of experiencing delays among cancer patients and it has become a wellestablished end point to determine the impacts of the disease on the life of patients. Delays in patient presentations to the medical professionals and delays in treatments are factors that lead to a progression of cancer and increase in mortality rates. The aim of this study is to know the association between health-related quality of life with patient presentation and treatment delays in Indonesia. Methods: This is a cross sectional study that took place in Siloam General Hospital, a suburban area of Tangerang from July 2016 to January 2017. Only solid-type cancers were included in our study. Health related quality of life was measured using EORTC QLQ-C30. Patients were classified as patient delays if the time from first symptoms to medical presentation were more than 3 months and classified as treatment delays if the time from diagnosis to medical treatment was more than 1 month. The statistical analysis was done by Independent T or Mann-Whitney test. Results: Out of a total of 56 patients, 50(89.3%) were female. The mean age of the patient was 48.6(þ/-10.9). The most common type of cancer was breast cancer (76. Objective: The purpose of this study is to create a prognostic index for patients with advanced lung cancer receiving best supportive care (BSC) by reviewing objective clinical parameters retrospectively. In multivariate analysis, Hb < 11.0, ALB<3.0, LDH > ¼320, ALP > ¼420, and CRP > ¼2.5 were independent factors associated with poor prognosis. OPPi was created with the above 5 factors. Each counted as one point and stratified patients into two groups, group A (0-2 points) and group B (3-5 points), to create survival curves. The median survival time of group A was 171 days while that of B was 36 days. For early death, defined as less than 42 days after the decision of BSC, sensitivity and specificity were 73.5% and 78.9% for group B, indicating validity of the OPPi.
Conclusion: This OPPi is a potential new method only using objective parameters comparing with the conventional prognostic prediction tool. This objective index might help in decision making of patients and family.
P3 À 290 An Effort of the cooperation between medical and dental service for the perioperative mouth care in our hospital
Tatsushi Kato, Ritsuko Sata, Syogo Kito, Yuya Nakamura, Hiroyuki Nakayama, Shigenori Kanazawa, Kazuyuki Yamaguchi, Ryuji Okamura Yamatotakada Munincipal Hospital
In recent years, the importance of the mouth care is rising as for the cancer care. As the measure to the necrosis-of-the-jaw-bone by bisphosphonate, our hospital had begun an effort to the mouth care. However, the addition of the medical service fee to the perioperative oral cavity function management was established in 2012, to improve QOL and the treatment results of the patient, and to reduce a medical expense. At the time everolimus appeared, and a countermeasure against stomatitis by everolims was needed, so we have deepened cooperation with the nearby dentist and the dental association in the area, holding a mouth care workshop regularly. So far the dental care at the time of the cancer care is a weak point at the medium-size hospital without dentistry like our hospital. However, by cooperation with the dentistry before the cancer care begins at present, it became possible to prevent the mouth trouble and to improve the quality of our cancer care. We report on former match and the problem in the future.
P3 À 335 The implementation of cancer survivorship care for Japanese expats and those families in a private clinic in Shanghai
Takashi Ishida, Masakata Matsumura, Aya Matsuda, Yuko Anzai, Kentaro Uchiyama, Junyao Liang, Ying Gao, Seishi Wada Shanghai Green Clinic Background: Our clinic offers medical treatment to Japanese expats and those families in Shanghai. China-resident Japanese cancer survivors occasionally consult us; however, their overseas medical needs and treatments have not been assessed comprehensively.
Methods: The medical records were retrospectively reviewed on the cancer survivors who consulted our clinic between 2014 and 2016. Results: We found 31 cancer survivors, including 22 (71%) males. The patients' age ranged from 34 to 86-year-old, and patients in their fifties were the most frequent. The tumors originated from 12 body sites; 8 (26%) tumors from the breast, and 7 (23%) tumors from the large intestine. 11 patients with cancer had been diagnosed at our clinic, and all of them were referred to Japan to undergo medical treatments; afterward, 6 patients of those returned to Shanghai expat. The medical care for cancer survivors provided at our clinic are as summarized below (overlap exists). In 4 expat patients, cancer chemotherapy had been continued in Shanghai. In cooperation with oncologists in Japan, our surgeon provided 3 postoperative breast cancer patients with endocrine therapy. One patient with gastric cancer had seen our internist for daily medical care, and he had visited medical oncologist concurrently for receiving cancer chemotherapy in Japan. 6 patients visited our clinic for cancer-related reasons; for recurrence survey (seeking endoscopic exam and/or tumor marker evaluation), or for relieving symptoms (restless legs syndrome, anxiety, or insomnia). 25 patients visited us having non-cancer related symptoms (common cold, epigastralgia, or diarrhea), or for requesting annual check-up and/or vaccine inoculation.
Conclusions: The needs of cancer survivors were various. We could attain some cancer chemotherapy for expat patients. Besides chemotherapy, daily medical care and mental supports were required. We can keep eliminating cancer-care disparities for expat cancer survivors in Shanghai. 
